Results 171 to 180 of about 27,623 (198)
Some of the next articles are maybe not open access.

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce   +2 more
exaly  

Chaperonin 10 for rheumatoid arthritis – Authors' reply

The Lancet, 2006
D Vanags   +3 more
openaire   +1 more source

XToll, a recombinant chaperonin 10 as an anti-inflammatory immunomodulator.

Current opinion in investigational drugs (London, England : 2000), 2008
CBio Ltd, under license from the University of Queensland, is developing a recombinant form of chaperonin 10, known as XToll, for the potential anti-inflammatory treatment of rheumatoid arthritis, psoriasis and multiple sclerosis. All three indications have been evaluated in phase IIa clinical trials.
openaire   +2 more sources

[17] Purification of yeast mitochondrial chaperonin 60 and co-chaperonin 10

1998
Yves Dubaquié   +2 more
openaire   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg   +2 more
exaly  

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein   +2 more
exaly  

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Ca-A Cancer Journal for Clinicians, 2018
Pricivel M Carrera   +2 more
exaly  

Home - About - Disclaimer - Privacy